Cinainu (dry aqueous extract of paullinia cupana seed;dry hydroethanolic extract of theobroma cacao seed;liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit)
- Region
- 🇪🇺 EU
- Active substance
- dry aqueous extract of paullinia cupana seed;dry hydroethanolic extract of theobroma cacao seed;liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit
- Company
- Legacy Healthcare (France) S.A.S.
- Status
- Application withdrawn
- Therapeutic area
- Alopecia Areata
- CHMP opinion
- Thu 14 Nov 2024
- Application
- EMEA/H/C/004155
- Official record
- www.ema.europa.eu
Indication
Treatment of alopecia areata in children and adolescents.
Regulatory milestones
No milestones recorded in the last year.
Follow Cinainu
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.